Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Hedge fund:636’

biotech research company, bio-technology companies

13D Filing: Aisling Capital III LP and Pernix Therapeutics Holdings Inc. (PTX)

Pernix Therapeutics Holdings Inc. (NASDAQ:PTX): Dennis Purcell’s Aisling Capital filed an amended 13D. You can check out Aisling Capital’s......(read more)
Pressmaster/Shutterstock.com

13D Filing: Aisling Capital III LP and Agile Therapeutics Inc (AGRX)

Agile Therapeutics Inc (NASDAQ:AGRX): Dennis Purcell’s Aisling Capital III LP filed an amended 13D. You can check out Aisling Capital’s latest......(read more)
Doctor Specialties with Best Lifestyle

13D Filing: Aisling Capital III LP and Loxo Oncology Inc. (LOXO)

Loxo Oncology Inc. (NASDAQ:LOXO): Dennis Purcell’s Aisling Capital III LP filed an amended 13D. You can check out Aisling Capital’s latest......(read more)
Medical devices, medical equipment

13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

Transenterix Inc. (NYSEMKT:TRXC): Dennis Purcell’s Aisling Capital III LP filed an amended 13D. You can check out Aisling Capital III LP’s......(read more)
Pressmaster/Shutterstock.com

13D Filing: Aisling Capital II LP and Adma Biologics Inc. (ADMA)

Adma Biologics Inc. (NASDAQ:ADMA): Dennis Purcell’s Aisling Capital II LP filed an amended 13D. You can check out Aisling Capital’s latest......(read more)
Sergey Nivens/Shutterstock.com

13G Filing: Aisling Capital IV, LP and GTx Inc (GTXI)

GTx Inc (NASDAQ:GTXI): Dennis Purcell’s Aisling Capital IV, LP filed an amended 13D. You can check out Aisling Capital’s latest holdings and......(read more)
Medical devices, medical equipment

13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Countries with Lowest Abortion Rates in the World in 2018

Agile Therapeutics Inc (AGRX) Stock: Aisling Capital Unloads 300,000 Shares

In a new 13D filing, Dennis Purcell‘s Aisling Capital reported lowering its stake in Agile Therapeutics Inc (NASDAQ:AGRX) to 2.28 million shares......(read more)
William Martin Raging Capital Management

Latest Moves Show Hedgies Are Not Giving Up On These 3 Cratered Stocks

One of the cornerstones of value investing is picking out companies that the market has written off, but which could be strong market players in the......(read more)
George Soros

The Latest Moves Made by Billionaire George Soros’ Firm and Other Hedge Funds

A little more than a year ago, the U.S. Securities and Exchange Commission announced charges against numerous officers, directors and significant shareholders......(read more)
healthcare

Is Dennis Purcell Trimming His Position In Roka Bioscience Inc. (ROKA) Too Early?

Dennis Purcell’s Aisling Capital trimmed its position in Roka Bioscience Inc. (NASDAQ:ROKA) by 246,049 shares in July. The hedge fund disclosed holding......(read more)
Samuel Isaly - Orbimed Advisors

Aisling Capital and OrbiMed Advisors See Value in This Canadian Pharmaceutical Company, Disclosing New Positions

Dennis Purcell’s Aisling Capital and Samuel Isaly’s OrbiMed Advisors have initiated new positions in Cynapsus Therapeutics Inc (NASDAQ:CYNA). In new......(read more)
NASDAQ:CEMP

Aisling Capital Reduces Stake in Cempra Inc (CEMP)

Dennis Purcell‘s Aisling Capital recently filed an amended 13D with the SEC disclosing a reduced stake in Cempra Inc (NASDAQ:CEMP). According to......(read more)
Esperion Therapeutics

Esperion Therapeutics Inc (ESPR), Cempra Inc (CEMP), Zeltiq Aesthetics Inc (ZLTQ): Aisling Capital’s Winning Plays in Small-Cap Healthcare Stocks

On Tuesday, Esperion Therapeutics Inc (NASDAQ:ESPR)‘s stock closed the trading section as one of the market leaders, ending the day up by 29%. The......(read more)

Aisling Capital Reported 12.7% Activist Stake in $ZLTQ

Aisling Capital announced 4.17 million shares in Zeltiq Aesthetics, Inc. (ZLTQ), corresponding to a 12.7% activist stake. No other hedge fund in our tracking......(read more)